Platelet Reactivity With Clopidogrel Versus Prasugrel in Patients With Systolic Heart Failure

Trial Profile

Platelet Reactivity With Clopidogrel Versus Prasugrel in Patients With Systolic Heart Failure

Completed
Phase of Trial: Phase IV

Latest Information Update: 04 Oct 2017

At a glance

  • Drugs Prasugrel (Primary) ; Clopidogrel
  • Indications Thrombosis
  • Focus Pharmacodynamics
  • Most Recent Events

    • 28 Sep 2017 Status changed from recruiting to completed.
    • 26 Feb 2014 Status changed from not yet recruiting to recruiting according to ClinicalTrial.gov record.
    • 24 Jan 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top